Cart
sales@molnova.com
Neurodazine
CAS No. 937807-66-4
Neurodazine( —— )
Catalog No. M33441 CAS No. 937807-66-4
Neurodazine is a neural inducer that promotes the differentiation of pluripotent cells into neuronal cells.Neurodazine promotes differentiation by activating Wnt and Shh signaling.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 78 | Get Quote |
|
| 10MG | 112 | Get Quote |
|
| 25MG | 178 | Get Quote |
|
| 50MG | 263 | Get Quote |
|
| 100MG | 381 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNeurodazine
-
NoteResearch use only, not for human use.
-
Brief DescriptionNeurodazine is a neural inducer that promotes the differentiation of pluripotent cells into neuronal cells.Neurodazine promotes differentiation by activating Wnt and Shh signaling.
-
DescriptionNeurodazine is a neurogenic inducer, serve as a promoter of neurogenesisin pluripotent cells. Neurodazine promotes neurogenesis by activating Wnt and Shh signaling pathways..
-
In VitroNeurodazine (5 μM; 1-10 d) treatment induces the expression of neuron-specific markers in P19 cells.Neurodazine selectively suppresses astrocyte differentiation of P19 cells.Western Blot Analysis Cell Line:P19 cells Concentration:5 μM Incubation Time:1-10 days Result:Induced the expression of neuron-specific markers.
-
In Vivo——
-
Synonyms——
-
PathwayWnt/Notch/Hedgehog
-
TargetWnt/beta/catenin
-
RecptorWnt/beta-catenin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number937807-66-4
-
Formula Weight456.92
-
Molecular FormulaC27H21ClN2O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (218.86 mM; Ultrasonic )
-
SMILESCOc1ccc(cc1)-c1nc([nH]c1-c1ccc(OC)cc1)-c1ccc(o1)-c1cccc(Cl)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kim GH, et al. Imidazole-based small molecules that promote neurogenesis in pluripotent cells. Angew Chem Int Ed Engl. 2014 Aug 25;53(35):9271-4.?
molnova catalog
related products
-
Vantictumab
Vantictumab (OMP-18R5) is a humanized anti-FZD1/2/5/7/8 monoclonal antibody that inhibits Wnt pathway signaling and is used in research studies for the treatment of metastatic HER2-negative breast cancer and metastatic pancreatic adenocarcinoma.
-
KY-05009
KY-05009 pharmacologically inhibits TGF-β1-induced epithelial-to-mesenchymal transition (EMT) in human lung adenocarcinoma cells.
-
TNKS-2-IN-2
TNKS-2-IN-2 is a novel and potent TNKS2 selective inhibitor (IC50: 22 nM) with potential anti-tumour activity for studying colon cancer, lung cancer, and breast cancer.
